Clinical Trials Logo

Anesthesia Emergence clinical trials

View clinical trials related to Anesthesia Emergence.

Filter by:
  • None
  • Page 1

NCT ID: NCT03219788 Not yet recruiting - Clinical trials for Anesthesia Emergence

Remifentanil and Desflurane Inhalational Anesthesia in Bariatric Surgeries

Start date: July 20, 2017
Phase: Phase 2
Study type: Interventional

The number of obese and overweighted persons doubled since 1980. They are 600 million in 2014 all over the world. Obesity results in anatomical, physiological and pharmacological changes which represent a challenge for every anesthetist. Difficult airway increases by 30% with obesity and so awake extubation are the preferred technique. Coughing can be alleviated by opioid receptors which play a role in the cough reflex. Remifentanil may be useful as an ultra-short acting opioid and its effect swiftly and predictably disappears after cessation. An emergence cough is attenuated by remifentanil administered via continuous infusion (TCI), and the expected effective effect-site concentrations investigated have ranged from 1.5 to 2.5 ng.ml/L.

NCT ID: NCT02141412 Completed - Clinical trials for Postoperative Recovery

Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

Start date: September 2009
Phase: Phase 4
Study type: Interventional

In a prospective randomized clinical trial involving adult patients undergoing elective surgery under general anesthesia, the investigators will enroll 216 patients, and evaluate 3 doses of prophylactic dexmedetomidine as a means to reduce postoperative shivering and quality of emergence from anesthesia versus placebo.